MABVAX THERAPEUTICS HLDGS IN's ticker is MBVX and the CUSIP is 55414P504. A total of 15 filers reported holding MABVAX THERAPEUTICS HLDGS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Biomark Capital Management Co. LLC | 26,708 | $37,000 | 0.06% |
Delaney Dennis R | 10,000 | $14,000 | 0.03% |
Bison Wealth, LLC | 15,000 | $21,000 | 0.02% |
BRIGHTON JONES LLC | 10,000 | $14,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 3 | $0 | 0.00% |
DEUTSCHE BANK AG\ | 3 | $0 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 7 | $0 | 0.00% |
UBS Group AG | 5,144 | $7,000 | 0.00% |
Sargent Bickham Lagudis LLC | 2 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 18,996 | $26,000 | 0.00% |